Covidien (COV) Nabs PolyTouch
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Join SI Premium – FREE
PolyTouch Medical Ltd. was acquired by Covidien (NYSE: COV).
PolyTouch Medical Ltd. developed a device for the precise and rapid deployment and placement of mesh during laparoscopic soft tissue repair procedures. PatchAssist", the leading product, was further developed to become AccuMesh", an innovative endomechanical device facilitating insertion, deployment and placement of mesh during laparoscopic ventral hernia repair. Covidien launched the AccuMesh device earlier this year.
PolyTouch was advised by Morgan Keegan & Company, Inc., now part of Raymond James & Associates, Inc.
PolyTouch Medical Ltd. developed a device for the precise and rapid deployment and placement of mesh during laparoscopic soft tissue repair procedures. PatchAssist", the leading product, was further developed to become AccuMesh", an innovative endomechanical device facilitating insertion, deployment and placement of mesh during laparoscopic ventral hernia repair. Covidien launched the AccuMesh device earlier this year.
PolyTouch was advised by Morgan Keegan & Company, Inc., now part of Raymond James & Associates, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Irenic Capital opposes Independence Realty's Centerspace deal - Bloomberg
- AAR To Pay $1.8B For Stake In Aircraft-maintenance Company - WSJ
- Quantum eMotion to acquire Plurilock in C$33.8M deal
Create E-mail Alert Related Categories
Mergers and AcquisitionsRelated Entities
Raymond James, Morgan Keegan & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
